OBIO
Orchestra BioMed Holdings Inc

525
Mkt Cap
$263.13M
Volume
464,397.00
52W High
$6.30
52W Low
$2.20
PE Ratio
-2.56
OBIO Fundamentals
Price
$4.43
Prev Close
$4.66
Open
$4.64
50D MA
$3.31
Beta
1.60
Avg. Volume
347,736.22
EPS (Annual)
-$1.66
P/B
6.02
Rev/Employee
$37,685.71
Loading...
Loading...
News
all
press releases
David Hochman Acquires 5,000 Shares of Orchestra BioMed (NASDAQ:OBIO) Stock
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO - Get Free Report) insider David Hochman purchased 5,000 shares of the firm's stock in a transaction that occurred on Friday, November 14th. The shares...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Orchestra BioMed (NASDAQ:OBIO) Insider Buys $20,350.00 in Stock
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO - Get Free Report) insider David Hochman acquired 5,000 shares of Orchestra BioMed stock in a transaction that occurred on Friday, November 14th. The...
MarketBeat·3d ago
News Placeholder
Research Analysts Offer Predictions for OBIO FY2025 Earnings
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO - Free Report) - Research analysts at HC Wainwright cut their FY2025 EPS estimates for Orchestra BioMed in a research note issued on Thursday, November...
MarketBeat·4d ago
News Placeholder
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO - Get Free Report) has been given a consensus rating of "Moderate Buy" by the six brokerages that are currently covering the firm, Marketbeat reports. One...
MarketBeat·6d ago
News Placeholder
Barclays Has Lowered Expectations for Orchestra BioMed (NASDAQ:OBIO) Stock Price
Barclays dropped their target price on shares of Orchestra BioMed from $12.00 to $11.00 and set an "overweight" rating on the stock in a report on Wednesday...
MarketBeat·7d ago
News Placeholder
Orchestra BioMed (NASDAQ:OBIO) Releases Earnings Results, Misses Expectations By $0.02 EPS
Orchestra BioMed (NASDAQ:OBIO - Get Free Report) announced its quarterly earnings data on Monday. The company reported ($0.40) EPS for the quarter, topping analysts' consensus estimates of ($0.44) by...
MarketBeat·9d ago
News Placeholder
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q3 Loss, Beats Revenue Estimates
Orchestra BioMed Holdings, Inc. (OBIO) delivered earnings and revenue surprises of -5.26% and +15.42%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·10d ago
News Placeholder
Orchestra BioMed Holdings Q3 Loss Widens
(RTTNews) - Orchestra BioMed Holdings, Inc. (OBIO) Monday reported a third-quarter net loss of $20.8 million or $0.40 per share, compared with a net loss of $15.4 million or $0.41 per share for the...
Nasdaq News: Markets·10d ago
News Placeholder
ADC Therapeutics SA (ADCT) Reports Q3 Loss, Tops Revenue Estimates
ADC Therapeutics (ADCT) delivered earnings and revenue surprises of +25.00% and +2.03%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·10d ago
News Placeholder
Orchestra BioMed Holdings, Inc. (OBIO) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Orchestra BioMed Holdings, Inc. (OBIO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·16d ago

Latest OBIO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.